Published in Proc Natl Acad Sci U S A on March 14, 2000
Three-dimensional MR mapping of angiogenesis with alpha5beta1(alpha nu beta3)-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse model. FASEB J (2008) 1.41
The N-terminal 70-kDa fragment of fibronectin binds to cell surface fibronectin assembly sites in the absence of intact fibronectin. Matrix Biol (2006) 1.26
Acquisition of regulators of complement activation by Streptococcus pyogenes serotype M1. Infect Immun (2002) 1.24
Novel laminin-binding protein of Streptococcus pyogenes, Lbp, is involved in adhesion to epithelial cells. Infect Immun (2002) 1.21
Interactions with fibronectin attenuate the virulence of Streptococcus pyogenes. EMBO J (2004) 1.12
Increased virulence of a fibronectin-binding protein mutant of Staphylococcus aureus in a rat model of pneumonia. Infect Immun (2002) 1.10
Recruitment of complement factor H-like protein 1 promotes intracellular invasion by group A streptococci. Infect Immun (2003) 1.06
Impact of the SpeB protease on binding of the complement regulatory proteins factor H and factor H-like protein 1 by Streptococcus pyogenes. Infect Immun (2005) 1.04
Streptococcal modulation of cellular invasion via TGF-beta1 signaling. Proc Natl Acad Sci U S A (2006) 0.90
Influenza viral neuraminidase primes bacterial coinfection through TGF-β-mediated expression of host cell receptors. Proc Natl Acad Sci U S A (2014) 0.89
Fibronectin bound to the surface of Staphylococcus aureus induces association of very late antigen 5 and intracellular signaling factors with macrophage cytoskeleton. Infect Immun (2003) 0.84
Identification of novel adhesins of M. tuberculosis H37Rv using integrated approach of multiple computational algorithms and experimental analysis. PLoS One (2013) 0.83
Knockdown of HMGN2 increases the internalization of Klebsiella pneumoniae by respiratory epithelial cells through the regulation of α5β1 integrin expression. Int J Mol Med (2016) 0.75
Integrins: versatility, modulation, and signaling in cell adhesion. Cell (1992) 34.06
Common themes in microbial pathogenicity revisited. Microbiol Mol Biol Rev (1997) 10.52
Integrins: emerging paradigms of signal transduction. Annu Rev Cell Dev Biol (1995) 8.88
MSCRAMM-mediated adherence of microorganisms to host tissues. Annu Rev Microbiol (1994) 7.14
Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease. Infect Immun (1995) 4.40
Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Lancet (1992) 3.46
Prevalence of internalisation-associated gene, prtF1, among persisting group-A streptococcus strains isolated from asymptomatic carriers. Lancet (1999) 2.61
Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection. J Clin Invest (1996) 2.57
An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. JAMA (1997) 2.52
Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerg Infect Dis (1996) 2.51
Protein F1 is required for efficient entry of Streptococcus pyogenes into epithelial cells. J Infect Dis (1998) 2.49
Group A streptococci efficiently invade human respiratory epithelial cells. Proc Natl Acad Sci U S A (1994) 2.39
The fibronectin-binding protein of Streptococcus pyogenes, SfbI, is involved in the internalization of group A streptococci by epithelial cells. Infect Immun (1997) 2.25
Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms. J Infect Dis (1997) 2.09
Streptococcus pyogenes serotype M1 encodes multiple pathways for entry into human epithelial cells. Infect Immun (1998) 1.70
Intracellular reservoir of Streptococcus pyogenes in vivo: a possible explanation for recurrent pharyngotonsillitis. Laryngoscope (1997) 1.67
M protein and protein F act as important determinants of cell-specific tropism of Streptococcus pyogenes in skin tissue. J Clin Invest (1994) 1.60
High-frequency intracellular invasion of epithelial cells by serotype M1 group A streptococci: M1 protein-mediated invasion and cytoskeletal rearrangements. Mol Microbiol (1999) 1.48
Entry of OpaA+ gonococci into HEp-2 cells requires concerted action of glycosaminoglycans, fibronectin and integrin receptors. Mol Microbiol (1998) 1.47
Severe invasive group A streptococcal disease: clinical description and mechanisms of pathogenesis. J Lab Clin Med (1996) 1.34
Invasion and survival of Streptococcus pyogenes in eukaryotic cells correlates with the source of the clinical isolates. J Infect Dis (1998) 1.23
Streptococcus pyogenes protein F promotes invasion of HeLa cells. Microbiology (1998) 1.04
Expression of different group A streptococcal M proteins in an isogenic background demonstrates diversity in adherence to and invasion of eukaryotic cells. Mol Microbiol (1999) 1.01
Intracellular penetration and survival of Streptococcus pyogenes in respiratory epithelial cells in vitro. Acta Otolaryngol (1995) 1.00
Antibiotic resistance: relationship to persistence of group A streptococci in the upper respiratory tract. Pediatrics (1996) 0.83
Oral antiplatelet efficacy of the platelet GPIIb/IIIa antagonist, DMP754 in non-human primates. Thromb Res (1998) 0.81
Novel nonpeptide antiplatelet glycoprotein IIb/IIIa receptor antagonist, DMP754: receptor binding affinity and specificity. Coron Artery Dis (1996) 0.80
Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet (1982) 54.79
Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system. Nature (1986) 4.01
Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin. Am J Pathol (2000) 3.18
C5a peptidase alters clearance and trafficking of group A streptococci by infected mice. Infect Immun (1996) 2.77
Analyses of the cytotoxic T lymphocyte responses to glycoprotein and nucleoprotein components of lymphocytic choriomeningitis virus. Virology (1988) 2.76
Streptococcus pyogenes type 12 M protein gene regulation by upstream sequences. J Bacteriol (1987) 2.54
Molecular characterization of the genomic S RNA segment from lymphocytic choriomeningitis virus. Virology (1987) 2.53
Group A streptococci efficiently invade human respiratory epithelial cells. Proc Natl Acad Sci U S A (1994) 2.39
Mechanism of action of the group A streptococcal C5a inactivator. Proc Natl Acad Sci U S A (1985) 2.38
Complete nucleotide sequence of the streptococcal C5a peptidase gene of Streptococcus pyogenes. J Biol Chem (1990) 2.31
Restricted deposition of C3 on M+ group A streptococci: correlation with resistance to phagocytosis. J Immunol (1982) 2.27
International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. J Thromb Haemost (2013) 2.24
Physical characterization of ten R plasmids obtained from an outbreak of nosocomial Klebsiella pneumoniae infections. Antimicrob Agents Chemother (1979) 2.21
Coregulation of type 12 M protein and streptococcal C5a peptidase genes in group A streptococci: evidence for a virulence regulon controlled by the virR locus. J Bacteriol (1990) 2.16
Insertional inactivation of streptolysin S expression in Streptococcus pyogenes. J Bacteriol (1983) 2.13
Nosocomial multiply resistant Klebsiella pneumoniae: epidemiology of an outbreak of apparent index case origin. Antimicrob Agents Chemother (1979) 2.13
Epidemiology of group-B streptococcal carriage in pregnant women and newborn infants. J Med Microbiol (1977) 2.12
Identification of a divergent M protein gene and an M protein-related gene family in Streptococcus pyogenes serotype 49. J Bacteriol (1989) 2.04
DNA fingerprinting of Streptococcus zooepidemicus (Lancefield group C) as an aid to epidemiological study. J Infect Dis (1987) 1.99
Fc-receptor and M-protein genes of group A streptococci are products of gene duplication. Proc Natl Acad Sci U S A (1989) 1.97
Inhibition of alternative complement pathway opsonization by group A streptococcal M protein. J Infect Dis (1979) 1.97
In vivo Streptococcus pyogenes C5a peptidase activity: analysis using transposon- and nitrosoguanidine-induced mutants. J Infect Dis (1987) 1.88
Site-specific antibodies define a cleavage site conserved among arenavirus GP-C glycoproteins. J Virol (1987) 1.87
Group B streptococci inhibit the chemotactic activity of the fifth component of complement. J Immunol (1988) 1.83
Group A streptococcal serotypes isolated from patients and sibling contacts during the resurgence of rheumatic fever in the United States in the mid-1980s. J Infect Dis (1989) 1.75
The S RNA segment of lymphocytic choriomeningitis virus codes for the nucleoprotein and glycoproteins 1 and 2. J Virol (1985) 1.74
Immobilized platelets support human colon carcinoma cell tethering, rolling, and firm adhesion under dynamic flow conditions. Blood (2000) 1.70
Streptococcus pyogenes serotype M1 encodes multiple pathways for entry into human epithelial cells. Infect Immun (1998) 1.70
Human neutrophil chemotactic response to group A streptococci: bacteria-mediated interference with complement-derived chemotactic factors. Infect Immun (1983) 1.70
Nucleotide substitutions and small-scale insertion produce size and antigenic variation in group A streptococcal M1 protein. Mol Microbiol (1993) 1.66
Expression of M type 12 protein by a group A streptococcus exhibits phaselike variation: evidence for coregulation of colony opacity determinants and M protein. Infect Immun (1987) 1.66
Pain control in inflammation governed by selectins. Nat Med (1998) 1.65
Identification of novel peptide antagonists for GPIIb/IIIa from a conformationally constrained phage peptide library. Proteins (1992) 1.63
Analysis of gene expression using simian virus 40 vectors. Anal Biochem (1983) 1.62
Genetic analysis of in vivo-selected viral variants causing chronic infection: importance of mutation in the L RNA segment of lymphocytic choriomeningitis virus. J Virol (1988) 1.62
Comparison of epidemic and endemic group G streptococci by restriction enzyme analysis. J Clin Microbiol (1990) 1.60
Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by the group A Streptococcus. Infect Immun (1997) 1.60
Genetic mapping of lymphocytic choriomeningitis virus pathogenicity: virulence in guinea pigs is associated with the L RNA segment. J Virol (1985) 1.60
Deletion and complementation analysis of biotin gene cluster of Escherichia coli. J Bacteriol (1972) 1.57
Characterization of prototype and clinically defined strains of Streptococcus suis by genomic fingerprinting. J Clin Microbiol (1990) 1.56
Location of promoter and operator sites in the biotin gene cluster of Escherichia coli. Proc Natl Acad Sci U S A (1972) 1.55
Conservation of the C5a peptidase genes in group A and B streptococci. Infect Immun (1996) 1.51
Evidence for group A-related M protein genes in human but not animal-associated group G streptococcal pathogens. Microb Pathog (1987) 1.51
Analysis of persistent virus infections by in situ hybridization to whole-mouse sections. Nature (1985) 1.50
High-frequency intracellular invasion of epithelial cells by serotype M1 group A streptococci: M1 protein-mediated invasion and cytoskeletal rearrangements. Mol Microbiol (1999) 1.48
Perineurial defect and peripheral opioid analgesia in inflammation. J Neurosci (1995) 1.45
Relative contributions of peripheral versus supraspinal or spinal opioid receptors to the antinociception of systemic opioids. Eur J Pain (2011) 1.44
Genetic instability of M protein and serum opacity factor of group A streptocci: evidence suggesting extrachromosomal control. Infect Immun (1975) 1.44
Analysis of the genomic L RNA segment from lymphocytic choriomeningitis virus. Virology (1987) 1.43
Virus-lymphocyte interactions. II. Expression of viral sequences during the course of persistent lymphocytic choriomeningitis virus infection and their localization to the L3T4 lymphocyte subset. J Immunol (1988) 1.42
VirR and Mry are homologous trans-acting regulators of M protein and C5a peptidase expression in group A streptococci. Mol Gen Genet (1993) 1.39
Resistance to phagocytosis by group A streptococci: failure of deposited complement opsonins to interact with cellular receptors. J Immunol (1985) 1.37
Identification of epidemic strains of Streptococcus suis by genomic fingerprinting. J Clin Microbiol (1991) 1.36
Arenaviruses: genomic RNAs, transcription, and replication. Curr Top Microbiol Immunol (2002) 1.35
Severe invasive group A streptococcal disease: clinical description and mechanisms of pathogenesis. J Lab Clin Med (1996) 1.34
A DNA substitution in the group A streptococcal bacteriophage SP24. Virology (1983) 1.34
Evidence consistent with horizontal transfer of the gene (emm12) encoding serotype M12 protein between group A and group G pathogenic streptococci. Infect Immun (1992) 1.32
Sequence heterogeneity in the termini of lymphocytic choriomeningitis virus genomic and antigenomic RNAs. J Virol (1994) 1.30
Cloning and expression of the gene for an immunoglobulin G Fc receptor protein from a group A streptococcus. Infect Immun (1987) 1.25
Bacteriophage control of antiphagocytic determinants in group A streptococci. J Exp Med (1980) 1.25
Plasmid macroevolution in a nosocomial environment: demonstration of a persistent molecular polymorphism and construction of a cladistic phylogeny on the basis of restriction data. Mol Gen Genet (1984) 1.24
Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis. Blood (2000) 1.22
Architecture of the vir regulons of group A streptococci parallels opacity factor phenotype and M protein class. J Bacteriol (1992) 1.22
Purification and characteristics of the streptococcal chemotactic factor inactivator. Infect Immun (1985) 1.22
Lymphocytic choriomeningitis virus induces a chronic wasting disease in mice lacking class I major histocompatibility complex glycoproteins. J Neuroimmunol (1993) 1.21
International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer. J Thromb Haemost (2013) 1.21
Opioid peptide-expressing leukocytes: identification, recruitment, and simultaneously increasing inhibition of inflammatory pain. Anesthesiology (2001) 1.21
P2Y12 receptor-mediated potentiation of thrombin-induced thromboxane A2 generation in platelets occurs through regulation of Erk1/2 activation. J Thromb Haemost (2006) 1.19
Role of hypoxia and extracellular matrix-integrin binding in the modulation of angiogenic growth factors secretion by retinal pigmented epithelial cells. J Cell Biochem (1999) 1.19
Insertional inactivation of virR in Streptococcus pyogenes M49 demonstrates that VirR functions as a positive regulator of ScpA, FcRA, OF, and M protein. FEMS Microbiol Lett (1995) 1.18
Purification of the proteinase from group B streptococci that inactivates human C5a. Biochim Biophys Acta (1991) 1.17
Molecular characterization of a cloned dolphin mitochondrial genome. J Mol Evol (1989) 1.16
Antagonists of integrin alpha v beta 3 inhibit retinal neovascularization in a murine model. Lab Invest (1996) 1.16
Why have group A streptococci remained susceptible to penicillin? Report on a symposium. Clin Infect Dis (1998) 1.16
Localization of the streptococcal C5a peptidase to the surface of group A streptococci. Infect Immun (1986) 1.15
Cloning and expression of the streptococcal C5a peptidase gene in Escherichia coli: linkage to the type 12 M protein gene. Infect Immun (1989) 1.15
Temporal analysis of transcription and replication during acute infection with lymphocytic choriomeningitis virus. Virology (1988) 1.13
Hospital distribution, persistence, and reintroduction of related gentamicin R plasmids. Antimicrob Agents Chemother (1986) 1.13
Sequence and type-specific immunogenicity of the amino-terminal region of type 1 streptococcal M protein. J Immunol (1987) 1.13
Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. V. Recognition is restricted to gene products encoded by the viral S RNA segment. J Immunol (1986) 1.12
Type M12 protein from Streptococcus pyogenes is a receptor for IgG3. J Immunol (1993) 1.11
Possible dual function of M protein: resistance to bacteriophage A25 and resistance to phagocytosis by human leukocytes. Infect Immun (1977) 1.08
Genetic dissection of the Streptococcus pyogenes M1 protein: regions involved in fibronectin binding and intracellular invasion. Microb Pathog (2001) 1.07
Sequence comparison among arenaviruses. Curr Top Microbiol Immunol (1987) 1.06
Identification of two type IIa IgG-binding proteins expressed by a single group A streptococcus. J Immunol (1992) 1.02
Hyaluronic acid capsule: strategy for oxygen resistance in group A streptococci. J Bacteriol (1979) 1.02
M12 protein from Streptococcus pyogenes is a receptor for immunoglobulin G3 and human albumin. Infect Immun (1994) 1.02
Tetraiodothyroacetic acid (tetrac) and nanoparticulate tetrac arrest growth of medullary carcinoma of the thyroid. J Clin Endocrinol Metab (2010) 1.00
The human antibody response to streptococcal C5a peptidase. J Infect Dis (1991) 1.00
Isolated DNA repeat region from fcrA76, the Fc-binding protein gene from an M-type 76 strain of group A streptococci, encodes a protein with Fc-binding activity. Mol Microbiol (1990) 0.99
Transcriptional control in the L-arabinose operon of Escherichia coli B-r. J Bacteriol (1974) 0.97
Selective alpha(v)beta(3)-receptor blockade reduces macrophage infiltration and restenosis after balloon angioplasty in the atherosclerotic rabbit. Circulation (2001) 0.96
Retracted High-frequency invasion of epithelial cells by Streptococcus pyogenes can be activated by fibrinogen and peptides containing the sequence RGD. Infect Immun (1997) 0.96
Construction and characterization of SV40 recombinants with beta-globin cDNA substitutions in their early regions. J Mol Appl Genet (1981) 0.96
Enzymic reduction of d-biotin d-sulfoxide to d-biotin. Methods Enzymol (1979) 0.96
Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia. Proc Natl Acad Sci U S A (1996) 0.96
Human PKR transfected into murine cells stimulates expression of genes under control of the HIV1 or HTLV-I LTR. Virology (1995) 0.95